Boatbuilder...you build a good case for a Buyout....as that is how it normally goes..However....our current Pandemic/Endemic casts a big shadow on the present socio/economic climate of the USA and abroad...and having a life-changing drug with multiple indications only requires one dam to burst....before the flood of interested parties comes to court us.....bidding will surely drive the share price beyond "Little Company" status....I believe that is where we are heading.....and I see our current producer as a courtier in the running...what better way to expand into Pharmaceuticals than with a winning Molecule spearheading your efforts....just some thoughts.